Variables | Estimate, (n (%)) |
---|---|
Participants | 136 (100%) |
Age (years, mean (sd)) | 38.8 (10.2) |
Sex | Â |
Women | 41 (30.2%) |
Men | 95 (69.8%) |
BMI (mean (sd)) | 24.7 (3.9) |
Missing data for BMI | 8 (6%) |
Ethnicity | Â |
Caucasian | 128 (94.1%) |
Others | 8 (5.9%) |
Lifelong tobacco smoking (pack-years) (mean (sd)) | 4.1 (9.5) |
Missing data for lifelong tobacco smoking | 6 (4.4%) |
Lifestyle | Â |
Active | 77 (56.6%) |
Inactive | 59 (43.4%) |
Employment duration (years, mean (sd)) | 6.7 (7.6) |
10-year cumulative exposure to nanomaterials | Â |
Particle number concentration (particles/cm3-yrs, median (IQR)) | 161,692 (462,168) |
LDSA (µm2/cm3-yrs, median (IQR)) | 305 (550) |
Pulmonary function and respiratory health | Â |
FEV1 < LLN | 15 (11.6%) |
FVC < LLN | 8 (6.2%) |
FEV1/FVC < LLN | 10 (7.8%) |
FEF25 − 75% < LLN | 10 (7.8%) |
Missing data for all pulmonary function parameters | 7 (5.1%) |
Asthmatics | 12 (8.8%) |
COPD cases | 1 (2.4%) |
Inflammatory biomarkers measured in EBC (pre-post shift average) | Â |
IL-10 (pg/mL, mean (sd)) | 1.88 (0.63) |
IL-1β (pg/mL, mean (sd)) | 0.51 (0.20) |
TNF-α (pg/mL, mean (sd)) | 0.19 (0.09) |
IL-10/TNF-α mean (sd) | 11.7 (5.4) |
Missing data for all inflammatory biomarkers | 7 (5.1%) |